Top 5 Beauty Startup Investors in Switzerland in January 2026
A list of 5 angel investors and VC (Venture Capital) funds that invest in Beauty startups based in Switzerland. We rank investors based on the number of investments they made in Beauty companies from Switzerland. We update this investor list every month.Top 5 Beauty Startup Investors in Switzerland in January 2026
| Investor | Beauty Switzerland investments |
|---|---|
| Ertan Wittwer | 2 |
| Yellowstone Holding | 1 |
| Giammaria Giuliani | 1 |
| Zürcher Kantonal Bank | 1 |
| UZH Life Sciences Fund | 1 |
Ertan Wittwer is the Founder and Board Member bestsmile. He attended BBZ Uzwil.
Show more
Investment focus
- Health Care, Water, Beauty
- Seed, Angel, Pre-Seed
- Switzerland, United States
Portfolio highlights
- Noriware — Noriware wants to revolutionize the packaging industry by offering a truly sustainable, home-compostable alternative to traditional plastic, through unlocking the potential of seaweed. In doing so, we want to be the leader in transparency to motivate the industry to become more sustainable.
- Alpine White — Alpine White is a healthcare startup that manufactures personal care products and treatments for its consumers. They exist to keep teeth healthy and white through great products and services that empower people to feel confident and feel good.
- Everyman Health — Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert.
Yellowstone Holding promoting new innovative products or technologies from Switzerland to the Asia market via our strong connections.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Series C
- Switzerland, Taiwan, Germany
Portfolio highlights
- Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- ZuriMED Technologies AG — Revolutionizing Soft Tissue Repair in Sports Medicine through Innovative Technologies
Giammaria Giuliani
Show more
Investment focus
- Beauty, Cosmetics
- Series A, Series B
- Switzerland
Portfolio highlights
- Cutiss — CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns.
Zürcher Kantonalbank is an independent, incorporated public-law institution is its public service mandate. Enshrined in law, it governs the bank's economic, social, and environmental commitment.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Seed, Series A, Funding Round
- Switzerland, Japan, Spain
Portfolio highlights
- BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
- TestResults — TestResults uses the TrueTest technology and AI-based virtual user that makes it possible for the first time to test autonomously across software, system, and technology boundaries from a user perspective with the same approach. The company has simplified automated testing massively and reduced time radically. With it, the automation andmaintenance effort is reduced to a minimum that allows zero flakiness and the enlightening feeling of being in control of automation and test scenarios.
- QualySense — QualySense is a Swiss start-up company focused on innovative high-throughput grain, beans and seeds sorting technology. QualySense develops a high-speed multi-tons per hour sorting device, which will change how grains, beans and seeds are processed and valued worldwide by assessing the biochemical quality of grains one by one. The QualySensesorters will enable customers to separate grain batches into different biochemical quality classes and sell the corresponding premium products at higher average prices. Food processors will be able to considerably increase the production value, and produce higher quality products in a non-interrupted process.
The UZH Life Sciences Fund involves two equal partners: the UZH Foundation and the Novartis Venture Fund. It seeks donations from private individuals, foundations and companies for the strategic priorities of the University of Zurich.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Funding Round, Seed, Convertible Note
- Switzerland
Portfolio highlights
- Occlufit — Occlufit is an occluder device that conforms to complex geometries and provides immediate sealing of cardiovascular defects.
- Navignostics — Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Art
Web3
Wellness
Organic Food
Android
Digital Media
Big Data
Manufacturing
Video Games
Construction
Sports
Publishing
Franchise
eSports
B2B
Mobile
Enterprise Software
Music
Food and Beverage
Email
Social Media
Payments
Social Network
Medical
Real Estate
Legal
Finance
Local
Internet
Education
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Financial Services
Mobile Advertising
Platforms
Cannabis
Automotive
Social
Retail
Wine And Spirits
Medical Device
Crowdfunding
CleanTech
Infrastructure
Mobile Apps
Transportation
InsurTech
Beauty
Enterprise
Photography
LGBT
Non Profit
Oil and Gas
Fashion
Film
Life Science
Theatre
Renewable Energy
SaaS
Restaurants
Sporting Goods
Software
Celebrity
Social Impact
Cryptocurrency
Facebook
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Ghana
Armenia
Egypt
Saudi Arabia
Belarus
Hungary
Finland
Oceania
France
Africa
Croatia
Gibraltar
Barbados
Georgia
LATAM
Greece
Czech Republic
Asia
Faroe Islands
Costa Rica
Hong Kong
Brazil
Bahrain
Belgium
Liechtenstein
Denmark
Bermuda
Panama
Estonia
Algeria
Ecuador
Bulgaria
Myanmar
Belize
Chile
Lithuania
Ethiopia
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Sweden
Malaysia
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Peru
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Liberia
Portugal
Jersey
El Salvador
Lebanon
Puerto Rico
Norway
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Mexico
Taiwan
Dominican Republic
Italy
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Mali
Honduras
Philippines
Isle of Man
Bolivia
Luxembourg
Pakistan
Israel
Albania
Kuwait
Mauritius
Romania
Jordan
Grenada
Argentina
Malta
Bangladesh
Morocco
Nicaragua
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Guatemala
Colombia
Seychelles
Marshall Islands
Investors in Switzerland by industry
Crowdfunding
Venture Capital
Transportation
eSports
Cryptocurrency
Finance
Food and Beverage
Medical
Fitness
Wellness
Medical Device
Email
Hardware
Social Media
Social Network
Internet
Digital Media
Manufacturing
Music
Android
Mobile
Blockchain
Construction
Software
Legal
Enterprise Software
Sports
Automotive
Hospitality
Travel
InsurTech
Biotechnology
Recruiting
Platforms
Mobile Advertising
Enterprise
FinTech
Consumer
Health Care
EdTech
Sustainability
Climate
Energy
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Gaming
Fashion
Mobile Apps
Web3
B2B
Life Science
Sporting Goods
Publishing
Education
Clean Energy
Financial Services
Renewable Energy
Real Estate
Beauty
Payments
CleanTech
Oil and Gas
Organic Food
Impact
Restaurants
Social Impact
Social
Infrastructure
Machine Learning
Non Profit
Agriculture (agtech)
Media (entertainment)
Biotech
Video Games
Big Data
Retail
Film